Trainers from five stables were fined thousands of dollars for breaching prohibited substance rules. New research might yet ...
E-reader fans like me aren't often offered interesting accessories or peripherals to change how we use our devices. You're lucky if your chosen book-alike is compatible with a stylus or keyboard.
In a glimpse into the future, a small number of executives have created AI replicas to take over some of their ...
Welcome to the C&C Group FY '26 Full Year Results. It's great to see you all, and a warm welcome to all of you, whether you are here in person in our offices in St. Paul's or indeed if you're joining ...
Most available drugs are effective for symptom control and structural protection, but they’re not perfect and new agents are being investigated to help close the treatment gap.
New Zealand King Salmon Co Ltd (NZX:NZK) reported a strong turnaround in its financial performance for the first half of fiscal year 2026, ending March 31. The company transitioned from a loss-making ...
The growth of the pulmonary arterial hypertension market is mainly driven by rising disease awareness, advances in targeted ...
Minor continues to demonstrate resilience and also the execution capability with a clear strategy in terms of growth in spite of the backdrop of what's happening today globally and also the volatile ...
FDA-approved EB therapies expand options for gene replacement and wound healing, but success depends on careful wound preparation and timing, experts say.
First quarter 2026 revenue of $50.2 million and adjusted EBITDA loss of $4.5 million, above and in line, respectively, with the Company’s guidance. Gross margin increased approximately 420 basis ...
Opinion

Recent Scoop Commentary

Recent Scoop Commentary Cindy Sheehan: "Brought to You by Boeing" - Before I headed to our "Gather-In of Hearts" in Central Park this afternoon, I was watching NBC's "Meet the Pre ...